Why did SPL rise 9.0% on 29 Oct 2025?
Starpharma · Pharmaceuticals, Biotechnology & Life Sciences
What moved it
Insufficient news evidence to determine the cause of the price move.
The provided news articles are generic market roundups and do not mention Starpharma Holdings or any specific event that would explain the abnormal price increase. There is no direct evidence tying the move to company announcements, sector trends, or other drivers.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice.
The evidence
In the news
Six microcaps to consider adding to your portfolio in 2025
moneymag.com.au · 30 Oct 2025
The Lithium Turnaround: Pilbara, Liontown, IGO, MinRes, and Global Lithium Resources to Watch
smallcaps.com.au · 30 Oct 2025
ASX Stock Market News | Australian Shares
smallcaps.com.au · 31 Oct 2025
Headlines link to the publisher.
Held by no ETF
Not currently held by any ETF we track.